Recommendations Developed for Primary Care Asthma Management in Veterans, Military Members
via HealthDayTUESDAY, Feb. 17, 2026 -- In a synopsis of a clinical practice guideline issued by the U.S. Department of Veterans Affairs and U.S. Department of Defense and published online Feb. 17 in the Annals of Internal Medicine, updated recommendations are presented for the primary care management of asthma in veterans and military members.
Amir Sharafkhaneh, M.D., Ph.D., from the Michael E. DeBakey VA Medical Center in Houston, and colleagues present updated recommendations regarding evaluation and management of veterans and military members with asthma. Twelve key questions were developed, and 21 evidence-based recommendations were advanced following evaluation of the evidence.
The authors note that inhaled corticosteroids are strongly recommended; management of asthma is streamlined with recommendations of a combination of inhaled corticosteroids and rapid-onset long-acting β-agonists as both reliever and controller agents, as well as step-up therapy by increasing inhaled corticosteroids and/or the addition of long-acting anticholinergic agents. Management of symptomatic gastroesophageal reflux disease and obesity are also supported for better control of asthma. Use of indoor air filtration devices is not suggested. Decision points are outlined for referral to a subspecialist.
"Asthma management within primary care is pivotal for enhancing patient outcomes and reducing health care burdens," the authors write.
Abstract/Full Text (subscription or payment may be required)
Editorial (subscription or payment may be required)
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2026-02-18 13:38
Read more
- Migraine Common in Women With Macromastia, Headache
- Risk Factors Associated With Child Food Allergy Identified
- FDA Approves Rybrevant Faspro (amivantamab and hyaluronidase-lpuj) as the Only EGFR-Targeted Therapy that can be Administered Once a Month
- Exercise Can Reduce Depression, Anxiety Symptoms
- FDA Expands Tater Tot Recall Tied to Possible Plastic Contamination
- Couples Who Do This One Thing Feel More Satisfied And Secure Together
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions